A multi-institutional team of British researchers has determined that evidence suggests a high prevalence of comorbid medical conditions and related complaints among people with dementia, and that the presence of dementia may complicate clinical care for other conditions, and undermine a patient’s ability to manage a chronic condition. The…
At the Faculty of Pharmacy of the University of the Basque Country (Basque – Euskal Herriko Unibertsitatea; Spanish – Universidad del Pas Vasco – UPV/EHU) in Leioa, northern Spain, encapsulation techniques are being developed to deliver correctly and effectively certain drugs used to treat neurological diseases. Enara Herran, a researcher…
An innovative laboratory culture system developed by an international team of investigators led by scientists of the Genetics and Aging Research Unit at Massachusetts General Hospital (MGH) provides the first clear evidence supporting the hypothesis that deposition of beta-amyloid plaques in the brain is the first step in…
Muses Labs, based at Research Triangle Park in Raleigh, North Carolina, creates software-based systems to enable personalized therapy for the treatment of complex diseases. The company recently announced the development of its first offering for addressing Alzheimer’s disease. The combination therapy it implements is based on a broad understanding…
The National Institutes of Health has announced its first wave of investments totaling $46 million in fiscal year ’14 funds to support the goals of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. The funding will enable more than 100 investigators in 15 states and several countries…
London based Alzheimer’s Disease International: The International Federation of Alzheimer’s Disease and Related Disorders Societies, Inc., supported by a grant from Bupa, has released its comprehensive and thoroughgoing World Alzheimer Report 2014: Dementia and Risk Reduction An Analysis Of Protective And Modifiable Factors. The paper reviews a wide range…
Findings of a new study from the University of Wisconsin-Madison’s Waisman Center investigating the link between a protein typically associated with Alzheimer’s disease, are revealing more information about the earliest stages of the neurodegenerative disease and that this protein’s impact on memory and cognition may not be as clear…
Experts from around the globe gathered in Toronto last week to discuss new approaches to the challenge increasing rates dementia present at an Organization for Economic Co-operation and Development (OECD) workshop organized in partnership with the Ontario Brain Institute (OBI) and the Institute of Health Policy, Management…
A new Open Access study published in the prestigious BMJ journal finds indication that use of benzodiazepines, widely prescribed drugs for treatment of anxiety and insomnia, is associated with an increased risk of developing Alzheimer’s disease, particularly for long-term users. These drugs, medically referred to as benzodiazepine receptor agonists,…
A study newly published in the journal Nature Neuroscience reveals that activity within the memory-oriented brain region of the hippocampus is in fact bidirectional, a key observation that could fuel new advancements into Alzheimer’s research. The study, entitled “Reversal of theta rhythm flow through intact hippocampal circuits,” (Nature…
Get regular updates to your inbox.